LifeMD, Inc.
LFMDNasdaqCIK 948320HealthcareFiscal year ends Dec 31
Reports and events: 227 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-04-0110:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-007652 |
| 2021-03-3016:47 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001493152-21-007194 |
| 2021-03-1916:15 ET | SC 13D | Ownership report, active investor | 0001493152-21-006434 |
| 2021-02-2617:00 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-21-004957 |
| 2021-02-2207:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-004461 |
| 2021-02-1208:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-003475 |
| 2021-02-1016:00 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-003253 |
| 2021-02-0417:00 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-21-002670 |
| 2021-02-0210:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-002352 |
| 2021-01-2817:30 ET | 8-K/A | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-002040 |
| 2021-01-2617:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-21-001825 |
| 2021-01-1916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-001316 |
| 2021-01-1416:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-21-001050 |
| 2021-01-1416:15 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-001049 |
| 2021-01-1116:15 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-000746 |
| 2020-12-2916:39 ET | S-1/A | Registration statement, amended | 0001493152-20-024458 |
| 2020-12-2817:10 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-20-024368 |
| 2020-12-1117:25 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-20-023418 |
| 2020-12-0716:29 ET | DEF 14A | Proxy statementPeriod 2020-12-07 | 0001493152-20-023039 |
| 2020-12-0317:00 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-20-022915 |
| 2020-11-2517:28 ET | S-1 | Registration statement | 0001493152-20-022576 |
| 2020-11-2517:05 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-022570 |
| 2020-11-2015:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-20-022078 |
| 2020-11-1716:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-021846 |
| 2020-11-1616:59 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001493152-20-021737 |
| 2020-11-1016:22 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-020933 |
| 2020-11-0409:27 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-20-020442 |
| 2020-10-2217:30 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-019842 |
| 2020-10-1910:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-019603 |
| 2020-10-1517:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-20-019512 |
| 2020-09-3016:59 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-20-018632 |
| 2020-09-2916:07 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-20-018539 |
| 2020-08-3108:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-20-016971 |
| 2020-08-1916:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-20-016307 |
| 2020-08-1716:59 ET | 8-K | 8.01 Other events | 0001493152-20-016112 |
| 2020-08-1417:05 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001493152-20-015934 |
| 2020-07-2817:18 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-20-014114 |
| 2020-06-1914:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-011479 |
| 2020-05-2716:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-20-009918 |
| 2020-05-1916:44 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001493152-20-009421 |
| 2020-05-0809:24 ET | 8-K | 8.01 Other events | 0001493152-20-008022 |
| 2020-03-3017:19 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001493152-20-005288 |
| 2020-03-2617:00 ET | 8-K/A | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights | 0001493152-20-004814 |
| 2020-02-2817:23 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights | 0001493152-20-003163 |
| 2020-01-2417:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-20-001789 |
| 2020-01-1617:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-20-001209 |
| 2019-12-1613:53 ET | DEF 14A | Proxy statementPeriod 2020-01-10 | 0001213900-19-026229 |
| 2019-12-1108:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-19-025824 |
| 2019-11-1415:45 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001213900-19-023444 |
| 2019-09-1113:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-19-017717 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.